{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:43:52Z","timestamp":1781225032672,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.medcli.2023.06.007","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T15:29:49Z","timestamp":1690817389000},"page":"417-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serum PLA2R antibody as a predictive biomarker for venous thromboembolism risk in primary membranous nephropathy"],"prefix":"10.1016","volume":"161","author":[{"given":"Jiayi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2023.06.007_bib0115","article-title":"Risk factors of venous thromboembolism in patients with nephrotic syndrome: a retrospective cohort study","author":"Shinkawa","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.medcli.2023.06.007_bib0120","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MAJ.0000000000000315","article-title":"Risk factors of pulmonary thrombosis\/embolism in nephrotic syndrome","volume":"348","author":"Yang","year":"2014","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.medcli.2023.06.007_bib0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pcl.2018.08.006","article-title":"Nephrotic syndrome","volume":"66","author":"Wang","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.medcli.2023.06.007_bib0130","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMcibr1209459","article-title":"Venous thrombosis in the nephrotic syndrome","volume":"368","author":"Loscalzo","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2023.06.007_bib0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ki.2011.312","article-title":"Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis","volume":"81","author":"Barbour","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.medcli.2023.06.007_bib0140","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/0886022X.2022.2057861","article-title":"Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathy","volume":"44","author":"Zhu","year":"2022","journal-title":"Ren Fail"},{"key":"10.1016\/j.medcli.2023.06.007_bib0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2023.06.007_bib0150","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.medcli.2023.06.007_bib0155","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s40620-018-0533-z","article-title":"Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy","volume":"31","author":"Tampoia","year":"2018","journal-title":"J Nephrol"},{"key":"10.1016\/j.medcli.2023.06.007_bib0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.autrev.2015.10.004","article-title":"Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)","volume":"15","author":"Radice","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2023.06.007_bib0165","first-page":"1825","article-title":"Clinical significance of autoantibodies in the assessment and treatment of idiopathic membranous nephropathy","volume":"17","author":"Han","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.medcli.2023.06.007_bib0170","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.ekir.2022.01.499","article-title":"POS-469 a retrospective analysis of venous thromboembolism incidence amongst patients with membranous nephropathy: a single centre experience is anti-PLA2R an accessory or an accomplice?","volume":"7","author":"Jeyalan","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.medcli.2023.06.007_bib0175","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.medcli.2023.06.007_bib0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.24920\/11809","article-title":"A cohort study of incidences and risk factors for thromboembolic events in patients with idiopathic membranous nephropathy","volume":"33","author":"Zou","year":"2018","journal-title":"Chin Med Sci J"},{"key":"10.1016\/j.medcli.2023.06.007_bib0185","doi-asserted-by":"crossref","first-page":"e4809","DOI":"10.1097\/MD.0000000000004809","article-title":"HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy","volume":"95","author":"Wen","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.medcli.2023.06.007_bib0190","doi-asserted-by":"crossref","first-page":"938","DOI":"10.21037\/atm-22-3572","article-title":"Phospholipase A2 receptor is associated with hypercoagulable status in membranous nephropathy: a narrative review","volume":"10","author":"Lu","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.medcli.2023.06.007_bib0195","doi-asserted-by":"crossref","first-page":"7343942","DOI":"10.1155\/2016\/7343942","article-title":"Attenuation of thrombosis by crude rice (Oryza sativa) bran policosanol extract: ex vivo platelet aggregation and serum levels of arachidonic acid metabolites","volume":"2016","author":"Wong","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.medcli.2023.06.007_bib0200","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jgr.2017.12.007","article-title":"Inhibitory effects of thromboxane A(2) generation by ginsenoside Ro due to attenuation of cytosolic phospholipase A(2) phosphorylation and arachidonic acid release","volume":"43","author":"Shin","year":"2019","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.medcli.2023.06.007_bib0205","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bbalip.2018.08.010","article-title":"Phospholipase A(2) catalysis and lipid mediator lipidomics","volume":"1864","author":"Mouchlis","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.medcli.2023.06.007_bib0210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000494662","article-title":"Antibodies against M-type phospholipase A2 receptor may predict treatment response and outcome in membranous nephropathy","volume":"48","author":"Qu","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.medcli.2023.06.007_bib0215","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/ckj\/sfac052","article-title":"Risk factors of venous thromboembolism in anti-PLA2R-positive and negative primary membranous nephropathy","volume":"15","author":"Wu","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.medcli.2023.06.007_bib0220","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.kint.2016.01.019","article-title":"Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?","volume":"89","author":"Hofstra","year":"2016","journal-title":"Kidney Int"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323003652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323003652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:57:05Z","timestamp":1758419825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775323003652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0025775323003652"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2023.06.007","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum PLA2R antibody as a predictive biomarker for venous thromboembolism risk in primary membranous nephropathy","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2023.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}